Implantable cardioverter-defibrillators

Heart

Volumn 86, Issue 2, 2001, Pages 221-226

  Connelly, D T ^a  

^a NATIONAL HEALTH SERVICE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; METOPROLOL; SOTALOL;

ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATION; DEFIBRILLATOR; DEVICE; DRUG COST; ELECTROPHYSIOLOGY; GRAFT INFECTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE PACING; HEART VENTRICLE TACHYCARDIA; HUMAN; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; QUALITY OF LIFE; SECONDARY PREVENTION; SUDDEN DEATH; SURGICAL TECHNIQUE; TREATMENT INDICATION;

ARRHYTHMIA; CLINICAL TRIALS; COST-BENEFIT ANALYSIS; DEFIBRILLATORS, IMPLANTABLE; HUMANS; PRACTICE GUIDELINES; QUALITY OF LIFE;

EID: 0034780324     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Resuscitation from out-of-hospital ventricular fibrillation: 4 years follow-up
2. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study)
3. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias
4. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings
5. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
6. Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone
7. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The cardiac arrest study Hamburg (CASH)
8. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials
9. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
10. A randomized study of the prevention of sudden death in patients with coronary artery disease
11. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery
12. The cost-effectiveness of automatic implantable cardiac defibrillators: Results from MADIT
13. Cost-effectiveness of the imptantable cardioverter-defibrillator: Results from the Canadian implantable defibrillator study (CIDS)
14. Prevention of implantable-defibrillator shocks by treatment with sotalol
15. AHA/NASPE medical/scientific statement. Personal and public safety issues related to arrhythmias that may affect consciousness: Implications for regulation and physician recommendations
16. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: A report of the ACC/AHA task force on practice guidelines (committee on pacemaker implantation)
17. Consensus statement on indications, guidelines for use, and recommendations for follow-up of implantable cardioverter defibrillators